49. 全身性エリテマトーデス Systemic lupus erythematosus Clinical trials / Disease details

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05063513 (ClinicalTrials.gov)	July 2009	6/5/2009	Autologous Stem Cell Transplantation: International Lupus Trial	Remission Induction Therapy for Refractory Systemic Lupus Erythematosus With Autologous Hematopoieti ...	REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS	Biological: Autologous Hematopoietic Stem Cell Transplantation;Drug: Rituximab	European Society for Blood and Marrow Transplantation	EULAR	Withdrawn	16 Years	60 Years	All	0	Phase 2/Phase 3	France
2	NCT00278538 (ClinicalTrials.gov)	September 23, 2005	15/1/2006	Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus ...	Cyclophosphamide and rATG/Rituximab in Patients With Systemic Lupus Erythematosus: Phase II Trial	Systemic Lupus Erythematosus	Biological: Hematopoietic stem cell transplantation	Northwestern University	NULL	Completed	15 Years	60 Years	All	32	Phase 2	United States
3	NCT00076752 (ClinicalTrials.gov)	January 30, 2004	2/2/2004	Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus	A Pilot Study of Intensified Lymphodepletion Followed by Autologous Hematopoietic Stem Cell Transpla ...	Lupus Erythematosus, Systemic	Drug: fludarabine phosphate;Drug: cyclophosphamide;Biological: Rituxan (rituximab);Biological: filgra ...	National Cancer Institute (NCI)	NULL	Completed	15 Years	40 Years	All	9	Phase 2	United States

First Previous1Next Last